MediPharm Labs To Supply VIVO Cannabis Subsidiary In Australia Partnership

Canadian cannabis company MediPharm Labs Corp. LABS MEDIF has inked a supply agreement with VIVO Cannabis IncVIVO VVCIF in an effort to expand in the Australian market.

Under the one-year deal — which is subject to renewal — MediPharm Labs Australia agreed to provide VIVO's Beacon Medical Australia with GMP-certified CBD and THC cannabis oil products. In addition, Beacon Medical will distribute them further under its branding.

Last month MediPharm Labs Australia confirmed it has obtained GMP Certification from Australian Therapeutic Goods Administration.

“We are excited to be working with VIVO to bring high quality products to medical consumers across Australia and other emerging markets,” said MediPharm Labs CEO, Asia Pacific, Warren Everitt in a Friday press release.

VIVO CEO Barry Fishman said the team-up with MediPharm Labs will "leverage their GMP production capabilities to accelerate our Australian market presence.”

“VIVO’s international efforts remain focused on the emerging Australian and German markets, and we continue to seek out partnerships with organizations that have proven track records,” he added.

MediPharm Labs also said its shipment of 35,000 units of formulated finished products and bulk extract to its Australian subsidiary - intended to back up sales revenue – Is finalized.

Meanwhile, last month MediPharm Labs Australia has debuted in Europe, by signing a supply deal with a subsidiary of Cannaray Ltd.

The company agreed to supply Cannaray’s Therismos Ltd. with cannabis oil products.

The expansion to the European market has come on the heels of another supply agreement the MediPharm Labs’ subsidiary entered into with New Zealand company Cannasouth CBD.

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsRetail Salescannabis industrycannabis salesCBD
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!